Notable Labs Ltd (NTBL)

$0.63

+0.04

(+7.57%)

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $0.55
    $0.64
    $0.63
    downward going graph

    12.7%

    Downside

    Day's Volatility :14.62%

    Upside

    2.2%

    downward going graph
  • $0.15
    $5.27
    $0.63
    downward going graph

    75.78%

    Downside

    52 Weeks Volatility :97.1%

    Upside

    88.05%

    downward going graph

Returns

PeriodNotable Labs LtdIndex (Russel 2000)
3 Months
-39.79%
0.0%
6 Months
-55.31%
0.0%
1 Year
-86.94%
0.0%
3 Years
-86.94%
-20.2%

Highlights

Market Capitalization
11.7M
Book Value
- $2.81
Earnings Per Share (EPS)
-1.61
Wall Street Target Price
9.0
Profit Margin
0.0%
Operating Margin TTM
-1434.43%
Return On Assets TTM
0.0%
Return On Equity TTM
0.0%
Revenue TTM
130.0K
Revenue Per Share TTM
0.01
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
8.0K
EBITDA
-12.6M
Diluted Eps TTM
-1.61
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.34
EPS Estimate Next Year
-1.6
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    87%Buy
    12%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Notable Labs Ltd(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1328.57%

Current $0.63
Target $9.00

Technicals Summary

Sell

Neutral

Buy

Notable Labs Ltd is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Notable Labs Ltd
Notable Labs Ltd
-8.55%
-55.31%
-86.94%
-86.94%
-86.94%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Notable Labs Ltd
Notable Labs Ltd
NA
NA
NA
-1.34
0.0
0.0
NA
-2.81
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Notable Labs Ltd
Notable Labs Ltd
Buy
$11.7M
-86.94%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Company Information

vascular biogenics ltd. is a biotechnology company located in 6yonatan netanyahu street, yehud, center district, israel.

Organization
Notable Labs Ltd
Employees
16
CEO
Dr. Thomas A. Bock M.B.A., M.D.
Industry
Miscellaneous

FAQs